Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Jury clears J&J of liability in California talc cancer case

Published 11/14/2018, 03:46 PM
Updated 11/14/2018, 03:46 PM
© Reuters. FILE PHOTO:  Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York

By Tina Bellon

(Reuters) - A California jury on Wednesday cleared Johnson & Johnson (N:JNJ) of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

The jury in Humboldt County Superior Court in Eureka, California rejected claims by Carla Allen who said that her mesothelioma, a tissue cancer closely linked to asbestos exposure, was caused by the company's talc products, including Johnson's Baby Powder.

J&J denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and asbestos-free.

Plaintiffs in the litigation allege that J&J knew of asbestos fibers in its cosmetic talc and concealed risks associated with the products.

The New Brunswick, New Jersey-based company faces some 11,700 U.S. talc lawsuits, according to an October regulatory filing. More than 9,700 of those cases involve claims over ovarian cancer, recent filings in New Jersey federal court, where most of the cases are consolidated, showed.

The remaining plaintiffs allege asbestos in J&J's talc caused them to develop mesothelioma.

J&J in a statement on Wednesday said it was pleased with the jury's decision in the case of Allen.

"While we deeply sympathize with anyone suffering from any form of cancer, the science and facts show that her disease was not caused by her use of our talcum-based products," the company said.

The California jury reached its decision following a roughly seven-week long jury trial, court records showed, but further details were not immediately available.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lawyers for Allen did not immediately respond to a request for comment.

J&J has been fighting talc cancer lawsuits for several years, but the litigation shifted in recent months to include allegations of asbestos contamination.

Plaintiffs now claim asbestos fibers in the products are causing both ovarian cancer and mesothelioma.

J&J to date has been cleared of liability in three mesothelioma cases. It has lost two mesothelioma cases in New Jersey and California, with juries awarding a total of $142 million in damages. Both cases are under appeal.

Four additional mesothelioma cases resulted in a mistrial because jurors could not reach a verdict or because the plaintiff died.

In July, a Missouri jury hit J&J with a massive $4.69 billion verdict in the first trial alleging asbestos contamination has caused ovarian cancer in 22 women. That decision is also under appeal.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.